Literature DB >> 23408310

Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' follow-up.

Ourania Alexandropoulou1, Lydia Kossiva, Fotis Haliotis, Maria Giannaki, Maria Tsolia, I P Panagiotou, Kyriaki Karavanaki.   

Abstract

The aim of the study was to identify the relationship of acquired neutropenia with childhood infections and to assess its clinical course, complications, and outcome. Children admitted to two pediatric wards over a 4-year period with febrile neutropenia were prospectively investigated for underlying infections with inflammatory markers, cultures of body fluids, and serological tests. The study included 161 previously healthy children with febrile neutropenia/leukopenia aged (mean ± SD) 3.02 ± 3.86 years (range, 0.1-14). One hundred and thirty-six out of 161 patients (84.5 %) had transient neutropenia (TN), while in 25 patients, neutropenia was chronic (CN) and persisted for ≥180 days. An infectious agent was isolated in 98/161 (60.9 %) cases, in 68.4 % patients with TN, and in 20 % of those with CN (p = 0.001). Among the patients with CN, seven had positive antineutrophil antibodies (autoimmune neutropenia) and four were eventually diagnosed with hematological malignancy. In all age groups, TN was of short duration (<1 month), of mild to moderate severity, and was predominantly associated with viral infections. Two years after diagnosis, 143/161 children (88.8 %) were available for follow-up. One hundred and thirty-seven of 143 (95.8 %) had recovered completely, while the rest remained neutropenic. The latter patients had a benign course despite severe neutropenia. In conclusion, febrile neutropenia during childhood is usually transient, often following viral and common bacterial infections, without serious complications and in the majority of cases it resolves spontaneously. However, in a considerable percentage of patients, neutropenia is discovered incidentally during the course of an infection on the ground of an underlying hematological disease.

Entities:  

Mesh:

Year:  2013        PMID: 23408310     DOI: 10.1007/s00431-013-1965-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  29 in total

1.  Outcomes of febrile children presumed to be immunocompetent who present with leukopenia or neutropenia to an ambulatory setting.

Authors:  J R Serwint; M M Dias; H Chang; M Sharkey; A R Walker
Journal:  Clin Pediatr (Phila)       Date:  2005-09       Impact factor: 1.168

Review 2.  Antigenic mimicry and autoimmune diseases.

Authors:  C Nickerson; H Luthra; C David
Journal:  Int Rev Immunol       Date:  1991       Impact factor: 5.311

3.  Two case studies of chronic idiopathic neutropenia preceding acute myeloid leukaemia.

Authors:  H W Auner; M Klintschar; R Crevenna; C Beham-Schmid; G Hoefler; G Mitterbauer; W Linkesch; H Sill
Journal:  Br J Haematol       Date:  1999-05       Impact factor: 6.998

Review 4.  Hematologic complications of HIV infection.

Authors:  Elaine Sloand
Journal:  AIDS Rev       Date:  2005 Oct-Dec       Impact factor: 2.500

5.  Infectious etiologies of transient neutropenia in previously healthy children.

Authors:  Entesar H Husain; Ali Mullah-Ali; Sondus Al-Sharidah; Asma F Azab; Adekunle Adekile
Journal:  Pediatr Infect Dis J       Date:  2012-06       Impact factor: 2.129

6.  Visceral leishmaniasis: a common cause of post-infectious febrile pancytopenia in children in an endemic area: experience of a children's tertiary hospital.

Authors:  Ourania Alexandropoulou; Maria Tsolia; Lydia Kossiva; Maria Giannaki; Kyriaki Karavanaki
Journal:  Pediatr Emerg Care       Date:  2012-06       Impact factor: 1.454

7.  Transient neutropenia of childhood.

Authors:  R Valiaveedan; S Rao; S Miller; A Brown
Journal:  Clin Pediatr (Phila)       Date:  1987-12       Impact factor: 1.168

8.  The clinical significance of non-malignant neutropenia in hospitalized children.

Authors:  Vasiliki Vlacha; Gavriella Feketea
Journal:  Ann Hematol       Date:  2007-07-25       Impact factor: 3.673

Review 9.  Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.

Authors:  I J Su; C H Wang; A L Cheng; R L Chen
Journal:  Leuk Lymphoma       Date:  1995-11

Review 10.  Primary and secondary autoimmune neutropenia.

Authors:  Franco Capsoni; Piercarlo Sarzi-Puttini; Alberto Zanella
Journal:  Arthritis Res Ther       Date:  2005-08-31       Impact factor: 5.156

View more
  6 in total

Review 1.  Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians.

Authors:  Piero Farruggia; Carlo Dufour
Journal:  Ther Adv Hematol       Date:  2015-02

2.  Diagnosis and therapeutic decision-making for the neutropenic patient.

Authors:  James A Connelly; Kelly Walkovich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

3.  Outcomes and infectious etiologies of febrile neutropenia in non-immunocompromised children who present in an emergency department.

Authors:  C Pascual; V Trenchs; S Hernández-Bou; A Català; A F Valls; C Luaces
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-18       Impact factor: 3.267

4.  Comparison of the etiologic, microbiologic, clinical and outcome characteristics of febrile vs. non-febrile neutropenia in hospitalized immunocompetent children.

Authors:  Eugene Leibovitz; Joseph Kapelushnik; Sabrin Alsanaa; Dov Tschernin; Ruslan Sergienko; Ron Leibovitz; Julia Mazar; Yariv Fruchtman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-07-27       Impact factor: 3.267

5.  Transient Neutropenia in Immunocompetent Infants with Respiratory Syncytial Virus Infection.

Authors:  Tatsuya Korematsu; Hiroshi Koga
Journal:  Viruses       Date:  2021-02-15       Impact factor: 5.048

6.  Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases.

Authors:  Sang Ngoc Nguyen; Lam Tung Vu; Quang Van Vu; Tham Thi Tran; Vi Tuong Thi Dinh
Journal:  Hematol Rep       Date:  2022-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.